PRP for Hair Loss: Evidence-Based Recommendations

Primary Recommendation

• The American College of Dermatology recommends PRP combined with topical minoxidil 5% twice daily as the most effective evidence-based treatment for androgenetic alopecia, demonstrating a 1.74-fold increase in hair density and 14.3-fold increase in hair diameter compared to baseline 1

Treatment Protocol

• The standard PRP administration protocol involves delivering three intradermal scalp injection sessions spaced exactly one month apart, using 5-7 mL PRP per session with 30-gauge × 4 mm needles, and injecting at a 90-degree angle, 2-4 mm depth, spacing injections 1 cm apart across mapped areas of hair loss 1, 2
• Maintenance injections every 6 months are required to sustain results long-term, according to the International Society of Hair Restoration Surgery 1, 3
• Nonactivated PRP demonstrates 31% greater increases in hair count and total hair density compared to activated PRP, as recommended by the American Academy of Dermatology 1, 2

Concurrent Therapy

• Topical minoxidil 5% at 1 mL twice daily must be applied throughout the treatment period and continued indefinitely, as recommended by the National Institute of Health 4, 2
• The triple combination (PRP + minoxidil + finasteride) represents the most effective evidence-based approach, according to the American College of Dermatology 3

Expected Outcomes and Timeline

• Initial improvements become visible at 2-3 months of continuous therapy, with a 25% improvement in hair density at 2 months predicting sustained response at 6 months, as reported by the International Journal of Trichology 1, 2
• Hair density increases by 1.74 times and hair diameter increases by 14.3 times at 6 months, according to the Journal of Clinical and Aesthetic Dermatology 4, 2

Efficacy Considerations

• PRP shows particular value in mild-to-moderate androgenetic alopecia cases, with more severe grades showing variable results, as reported by the American Academy of Dermatology 2
• Combination therapy with PRP and topical minoxidil 5% is significantly more effective than either monotherapy, according to the National Institute of Health 2

Safety Profile and Adverse Effects

• Pain during injection is the primary complaint, with minimal morbidity and low cost, as reported by the Journal of Clinical and Aesthetic Dermatology 2, 5

Emerging Alternative: Platelet-Rich Fibrin (PRF)

• PRF is emerging as a potentially superior alternative to PRP, offering theoretical advantages with similar efficacy and lower cost, according to the International Journal of Trichology 2, 4

Evidence Quality and Limitations

• The evidence for PRP remains somewhat controversial due to highly variable study protocols, preparations, and treatment intervals, as reported by the American College of Dermatology 1
• Improved and standardized study designs with larger samples, quantitative measurements, and longer follow-up periods are needed, according to the National Institute of Health 4

Monitoring Treatment Response

• Trichoscopy should be used to evaluate hair density and diameter at 2, 3, and 6 months, along with standardized before-and-after photographs and patient self-assessment questionnaires, as recommended by the International Society of Hair Restoration Surgery 1

Evidence‑Based Guidelines for PRP + Minoxidil Therapy in Androgenetic Alopecia

Efficacy of Combination Therapy

• PRP combined with topical minoxidil 5 % is significantly more effective than either PRP alone or minoxidil alone, and both are superior to placebo. 6

Critical Success Factors

• Higher platelet concentrations in PRP produce greater improvements in hair density, follicle diameter, and terminal‑hair density. 7
• Administering an adequate PRP volume of 5–7 mL per session is essential for optimal clinical response. 7
• Maintaining the recommended treatment frequency (initial three monthly sessions followed by maintenance every 6 months) is required; insufficient frequency leads to therapeutic failure. 7

Application Method Comparison

• Microneedling delivery of PRP is superior to standard injection technique for promoting anagen‑phase activity, reducing telogen‑phase hairs, and increasing average hair length. 7

Safety and Tolerability

• Topical minoxidil is better tolerated than PRP because it avoids injection‑related pain. 6

Monitoring and Assessment

Objective Measurements

• Perform quantitative hair counts in predefined scalp regions before treatment and at follow‑up visits. 7
• Measure hair‑shaft diameter with a micrometer or specialized imaging tools to assess changes over time. 7
• Conduct trichogram analysis using computer software to evaluate hair density, shaft diameter, and the terminal‑to‑vellus hair ratio. 7

Clinical Assessment

• Capture standardized before‑and‑after photographs for visual comparison of treatment effect. 7
• Perform a pull test; a reduction in the number of hairs extracted indicates improved hair‑shaft strength. 7
• Apply a Global Physician Assessment (GPA) scoring system to grade overall clinical improvement. 7
• Use patient‑reported outcome questionnaires to gauge satisfaction and perceived benefit. 7

Mechanistic Evidence

• PRP enhances proliferative activity of hair‑follicle cells, demonstrated by increased expression of β‑catenin, CD34, Ki‑67, and Dkk‑1 markers. 7
• Histologic analysis shows an increased number of basal keratinocytes after PRP treatment. 7
• Epidermal thickness is improved following PRP therapy. 7

Critical Pitfalls to Avoid

• Do not rely on PRP monotherapy; combining PRP with minoxidil 5 % is required for significant efficacy. 6